JP2009221205A5 - - Google Patents

Download PDF

Info

Publication number
JP2009221205A5
JP2009221205A5 JP2009110392A JP2009110392A JP2009221205A5 JP 2009221205 A5 JP2009221205 A5 JP 2009221205A5 JP 2009110392 A JP2009110392 A JP 2009110392A JP 2009110392 A JP2009110392 A JP 2009110392A JP 2009221205 A5 JP2009221205 A5 JP 2009221205A5
Authority
JP
Japan
Prior art keywords
indole
carboxamide
morpholin
sulfonyl
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009110392A
Other languages
English (en)
Japanese (ja)
Other versions
JP5261275B2 (ja
JP2009221205A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009221205A publication Critical patent/JP2009221205A/ja
Publication of JP2009221205A5 publication Critical patent/JP2009221205A5/ja
Application granted granted Critical
Publication of JP5261275B2 publication Critical patent/JP5261275B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009110392A 2002-08-09 2009-04-30 チロシンキナーゼ阻害薬 Expired - Fee Related JP5261275B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40247802P 2002-08-09 2002-08-09
US60/402,478 2002-08-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004527799A Division JP4332112B2 (ja) 2002-08-09 2003-08-05 チロシンキナーゼ阻害薬

Publications (3)

Publication Number Publication Date
JP2009221205A JP2009221205A (ja) 2009-10-01
JP2009221205A5 true JP2009221205A5 (enExample) 2009-11-26
JP5261275B2 JP5261275B2 (ja) 2013-08-14

Family

ID=31715862

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004527799A Expired - Fee Related JP4332112B2 (ja) 2002-08-09 2003-08-05 チロシンキナーゼ阻害薬
JP2009110392A Expired - Fee Related JP5261275B2 (ja) 2002-08-09 2009-04-30 チロシンキナーゼ阻害薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004527799A Expired - Fee Related JP4332112B2 (ja) 2002-08-09 2003-08-05 チロシンキナーゼ阻害薬

Country Status (8)

Country Link
US (2) US7560546B2 (enExample)
EP (1) EP1534695B1 (enExample)
JP (2) JP4332112B2 (enExample)
AT (1) ATE482938T1 (enExample)
AU (1) AU2003261415C1 (enExample)
CA (1) CA2494962C (enExample)
DE (1) DE60334386D1 (enExample)
WO (1) WO2004014851A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003257170B2 (en) * 2002-08-09 2008-12-11 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
DE60334386D1 (de) * 2002-08-09 2010-11-11 Merck Sharp & Dohme Tyrosinkinaseinhibitoren
SE0302811D0 (sv) * 2003-10-23 2003-10-23 Astrazeneca Ab Novel compounds
JO2724B1 (en) * 2004-08-19 2013-09-15 افينتس فارماسوتيكالز انك 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors
CA2605778A1 (en) 2005-04-20 2006-10-26 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
EP1899340A4 (en) * 2005-06-28 2009-09-16 Merck & Co Inc NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
TWI380973B (zh) * 2005-06-30 2013-01-01 Smithkline Beecham Corp 化合物
US20090131494A1 (en) * 2005-08-11 2009-05-21 Williams Theresa M Non-Nucleoside Reverse Transcriptase Inhibitors
US8247403B2 (en) 2007-03-07 2012-08-21 Takeda Pharmaceutical Company Limited Benzoxazepine derivatives and use thereof
US8642067B2 (en) 2007-04-02 2014-02-04 Allergen, Inc. Methods and compositions for intraocular administration to treat ocular conditions
EP2417123A2 (en) 2009-04-06 2012-02-15 Agios Pharmaceuticals, Inc. Therapeutic compositions and related methods of use
WO2010138490A1 (en) * 2009-05-26 2010-12-02 Exelixis, Inc. Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
CA2944788C (en) 2009-06-29 2023-08-22 Agios Pharmaceuticals, Inc. Compounds, and compositions thereof, which modulate pyruvate kinase m2, and methods of making same
EP2448581B1 (en) 2009-06-29 2016-12-07 Agios Pharmaceuticals, Inc. Therapeutic compositions and related methods of use
JP5837091B2 (ja) 2010-12-17 2015-12-24 アジオス ファーマシューティカルズ, インコーポレイテッド ピルビン酸キナーゼm2(pkm2)調節剤としての新規n−(4−(アゼチジン−1−カルボニル)フェニル)−(ヘテロ−)アリールスルホンアミド誘導体
JP6092118B2 (ja) 2010-12-21 2017-03-08 アジオス ファーマシューティカルズ, インコーポレイテッド ニ環式pkm2活性化剤
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
CA2833009A1 (en) * 2011-04-21 2012-10-26 Merck Sharp & Dohme Corp. Insulin-like growth factor-1 receptor inhibitors
WO2012151440A1 (en) 2011-05-03 2012-11-08 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
KR101873543B1 (ko) 2011-05-03 2018-07-02 아지오스 파마슈티컬스 아이엔씨. 치료에 사용하기 위한 피루베이트 키나아제 활성제
US8748446B2 (en) 2012-03-03 2014-06-10 Nanoquantum Sciences, Inc. Halogenated compounds for photodynamic therapy
US20150119394A1 (en) * 2012-03-28 2015-04-30 Merck Sharp & Dohme Corp. Insulin-Like Growth Factor-1 Receptor Inhibitors
RU2680100C9 (ru) 2013-03-15 2019-04-18 Плексксикон Инк. Гетероциклические соединения и их применения
WO2014139144A1 (en) 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US20140303121A1 (en) 2013-03-15 2014-10-09 Plexxikon Inc. Heterocyclic compounds and uses thereof
DK3307271T3 (da) 2015-06-11 2023-10-09 Agios Pharmaceuticals Inc Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer
US10717735B2 (en) 2017-10-13 2020-07-21 Plexxikon Inc. Solid forms of a compound for modulating kinases
KR20250019039A (ko) * 2022-06-02 2025-02-07 시젱 하이스코 파마수티칼 씨오., 엘티디. 헤테로고리 화합물 ccr4 억제제 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1410699A (fr) 1963-10-07 1965-09-10 Upjohn Co Nouveaux indols
US3209011A (en) * 1963-10-07 1965-09-28 Upjohn Co 3-[(alkylcarbamoyl) sulfamoyl]-1-alkylindole-2-carboxylic acids and esters thereof
US3180875A (en) * 1963-10-07 1965-04-27 Upjohn Co Derivatives of 3, 3'-dithiobis[indole-2-carboxylic acid] dihydrazides
BR8204028A (pt) 1981-07-16 1983-07-05 Du Pont Composto herbicida composicao adequada e processo para controlar o crescimento de vegetacao indesejada
US5527819A (en) * 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
WO1994019321A1 (en) * 1993-02-24 1994-09-01 Merck & Co., Inc. Inhibitors of hiv reverse transcriptase
EP1048657A1 (en) 1995-04-04 2000-11-02 Texas Biotechnology Corporation Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
WO1998050356A1 (en) 1997-05-07 1998-11-12 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
MXPA04003758A (es) 2001-10-22 2005-06-20 Univ New York State Res Found Inhibidores de proteina - cinasas y proteina-fosfatasas, metodos para disenarlos y metodos para usarlos.
AU2003257170B2 (en) 2002-08-09 2008-12-11 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
DE60334386D1 (de) * 2002-08-09 2010-11-11 Merck Sharp & Dohme Tyrosinkinaseinhibitoren

Similar Documents

Publication Publication Date Title
JP2009221205A5 (enExample)
CA2494962A1 (en) Tyrosine kinase inhibitors
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
RU2482111C2 (ru) Соединения, обладающие противораковой активностью
JP2013517273A5 (enExample)
RU2009103313A (ru) Индолы в качестве модуляторов 5-нт6
JP2011102294A (ja) ヘテロアリール置換された1,3−ジヒドロインドール−2−オン誘導体および該誘導体を含有する医薬品
AU732863B2 (en) Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagonist activity
PE20090717A1 (es) Derivados de quinolina como inhibidores de la pi3 quinasa
JP2013544840A5 (enExample)
JP2004509953A5 (enExample)
RU2006129492A (ru) Производные индола и их применение в качестве ингибиторов киназ, в частности, ингибиторов ikk2
US20040127536A1 (en) Methods for treating an inflammatory condition or inhibiting JNK
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
JP2010529991A5 (enExample)
RU2006117635A (ru) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
PE20080944A1 (es) Derivados de pirimidina como inhibidores del receptor de cinasa activina(alk-5)
JP2009537545A5 (enExample)
JP2006505522A5 (enExample)
RU2013133800A (ru) Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний
JP2004531473A5 (enExample)
JP2008500320A5 (enExample)
RU2009138219A (ru) Новые бензамидные производные и способ их получения
JP2005531501A5 (enExample)
JP2006519258A5 (enExample)